The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.

British Journal of Clinical Pharmacology

Volumn 30, Issue 4, 1990, Pages 593-598

  Helsby, NA ^a   Ward, SA ^a   Edwards, G ^a   Howells, RE ^a   Breckenridge, AM ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOGUANIL; PROGUANIL;

ARTICLE; DRUG METABOLISM; HUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

BIOTRANSFORMATION; CHLOROGUANIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMAN; SPECTROPHOTOMETRY, ULTRAVIOLET; SUPPORT, NON-U.S. GOV'T; TRIAZINES;

EID: 0025038681     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1990.tb03818.x     Document Type: Article

References (13)

1. Defective N‐oxidation of sparteine in man; a new pharmacogenetic defect
2. Characterization and inhibition of mephenytoin 4‐hydroxylase activity in human liver microsomes
3. In vitro metabolism of the biguanide antimalarials in human liver microsomes: Evidence for a role of the mephenytoin hydroxylase (P450MP) enzyme
4. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man
5. The absorption and excretion of Paludrine in the human subject
6. Polymorphic hydroxylation of debrisoquine in man
7. Phenformin‐induced lactic acidosis associated with impaired debrisoquine hydroxylation
8. Determination of proguanil and its metabolites cycloguanil and 4‐chlorophenyl‐biguanide in plasma, whole blood and urine by hplc
9. Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man
10. A preliminary pharmacokinetic study of the anti‐malarial drugs, proguanil and chlorproguanil
11. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects
12. Mephenytoin hydroxylation deficiency in caucasians: frequency of a new oxidative drug metabolism polymorphism